Alexion Pharmaceuticals (ALXN)

Add to Watchlists Create an Alert
160.86 -0.67  -0.41% NASDAQ Sep 18, 3:43PM BATS Real time Currency in USD
View Full Chart
ALXN Price Chart
View All Events

ALXN Events

Date Type Description
07/24/2014 10:00 EDT Misc Alexion Pharmaceuticals Incorporated Second Quarter 2014 Results Conference Call
07/24/2014 Earnings Alexion Pharmaceuticals to Report Second Quarter 2014 Results on Thursday, July 24, 2014
05/05/2014 17:00 CDT Misc AGM Event for Alexion Pharmaceuticals Inc.
05/05/2014 Misc Annual General Meeting for Alexion Pharmaceuticals Inc
04/24/2014 10:00 EDT Misc Alexion Pharmaceuticals, Inc. Q1 2014 Earnings Conference Call
04/24/2014 Earnings Alexion Pharmaceuticals, Inc. Q1 2014 Earnings Results
01/30/2014 10:00 EST Misc Alexion Pharmaceuticals Q4 2013 Earnings Conference Call
01/30/2014 Earnings Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2013 Results on Thursday, January 30, 2014
10/24/2013 10:00 EDT Misc Q3 2013 Alexion Pharmaceuticals Earnings Conference Call
10/24/2013 Earnings Alexion Pharmaceuticals to Report Third Quarter 2013 Results on Thursday, October 24, 2013
View All Performance Charts

ALXN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Alexion Pharmaceuticals is up 40.81% over the last year vs S&P 500 Total Return up 20.48%, Gilead Sciences up 68.13%, and Biogen Idec up 36.86%.

Get Quote for

PDF Report for ALXN

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ALXN Pro Report PDF

Portfolio Strategies Featuring ALXN

Did Alexion Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ALXN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website:
  • IR Website:
  • HQ Country: United States
  • HQ State/Province: Connecticut
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Research and Development in Biotechnology
  • NAICS Code: 541711
  • NAICS Industry: Scientific Research and Development Services
  • NAICS Sector: Professional, Scientific, and Technical Services

Alexion Pharmaceuticals Inc is a biopharmaceutical company engaged in serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.

ALXN Excel Add-In Codes

  • Name: =YCI("ALXN","name")
  • Description: =YCI("ALXN","description")
  • Sector: =YCI("ALXN","sector")
  • Industry: =YCI("ALXN","industry")
  • Est. Current Fiscal Year End: =YCI("ALXN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start your {{}} Membership


{{ ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{}} Member? Sign in here.